ASX Announcement 24 August 2026 Cleo Diagnostics Ltd ASX: COV Level 2, 480 Collins Street, Melbourne, VIC, 3000 ACN 655 717 169 T +61 3 9614 0600 E office@cleodx.com Directors Chair and Non-Executive Director Adrien Wing Chief Executive Officer and...
Cleansing Notice
Filed with ASX · · 1 page · English
Release
Story so far
Earlier from CLEO Diagnostics
- Application for quotation of securities - COV
- Notification of cessation of securities - COV
- Change in Director's Interest Notice
- Appendix 4E and 2026 Annual Report
- Appendix 4G and Corporate Governance Statement
Later from CLEO Diagnostics
- Change of Director's Interest Notice x 4
- CLEO Receives First Batch of Commercial Test Kits
- CLIA Certified Lab selected - Pivotal US Clinical Validation
- Notice Required Under ASX Listing Rule 3.13.1
- Notice of Annual General Meeting/Proxy Form
Follow CLEO Diagnostics into a list and get an email when it puts out news.
Follow CLEO Diagnostics